PFE Pfizer Inc.

Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT

NEW YORK--(BUSINESS WIRE)--

Due to today’s announcement of a proposed transaction between Pfizer and Mylan, Pfizer’s second-quarter 2019 earnings conference call with investment analysts has been rescheduled for today, July 29, 2019, at 10:30 a.m. EDT. This call was previously scheduled for Tuesday, July 30, 2019 at 10 a.m. EDT.

To view and listen to the webcast and view the Performance Report, visit our web site at . Information on accessing and pre-registering for the webcast is available at today. Participants are advised to pre-register in advance of the conference call.

You can also listen to the conference call by dialing either (855) 895-8759 in the United States and Canada or (503) 343-6044 outside of the United States and Canada. The password is “Second Quarter Earnings.”

Visitors to will be able to view and listen to an archived copy of the webcast of the conference call.

EN
29/07/2019

Underlying

PFEPfizer Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pfizer Inc.

PFE PFIZER INC.

Pfizer Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

12/08/25 December 8, 2025 1 EN
EUR 152.01
PFE PFIZER INC.

Moody's Ratings assigns A2 rating to Pfizer's notes; outlook stable

Moody's Ratings (Moody's) assigned a A2 rating to the new senior unsecured notes offering of Pfizer Inc. (Pfizer). There are no changes to Pfizer's existing ratings including the A2 long-term issuer rating, the A2 senior unsecured notes, the A2 senior unsecured revolving credit facility, or the Prim...

11/18/25 November 18, 2025 1 EN
PFE PFIZER INC.

Pfizer Inc.: Update to credit analysis

Our credit view of this issuer reflects its good scale, diversity and pipeline opportunities, weighed against its large patent exposures towards the end of the decade.

10/27/25 October 27, 2025 1 EN
Gary Brode
  • Gary Brode
LLY ELI LILLY AND COMPANY
BMY BRISTOL-MYERS SQUIBB COMPANY
PFE PFIZER INC.
10/06/25 October 6, 2025 1 EN
EUR 152.01
PFE PFIZER INC.

Moody's Ratings assigns A2 rating to Pfizer's subsidiary notes offerin...

Moody's Ratings ("Moody's") assigned a A2 rating to the proposed euro-denominated senior unsecured notes offering by Pfizer Netherlands International Finance B.V. (PNIF BV), a wholly-owned subsidiary of Pfizer Inc. (Pfizer). We also assigned a stable outlook to PNIF BV. The A2 rating assigned to P...

05/14/25 May 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch